CME Symposium - The Evolving Landscape of Oral Antiplatelet Therapy for Acute Coronary Syndromes

PRLog (Press Release) - Feb. 12, 2013 - This program will address profiles of established and new antiplatelet drugs; efficacy and safety data from ACS trials involving aspirin, clopidogrel, prasugrel, and ticagrelor; and use of therapies in post- hospital discharge management. Duration of therapy will be discussed to optimize the balance of ischemic vs bleeding risk, and patient compliance. In addition, case presentation and faculty panel discussion will identify current guideline-directed medical therapies and cardiometabolic risk factor goals to achieve, highlighting best strategies and practices in secondary prevention.

Wednesday, April 10, 2013

Register online at: http://www.symposiareg.com/2132
Walk-Ins are welcome*

Registration and Dinner: 6:00 PM - 6:30PM
Symposium: 6:30PM - 8:30PM

Yerba Buena Ballroom - Salon 8
San Francisco Marriott Marquis
55 Fourth Street
San Francisco, CA

Chair
Deepak Bhatt, MD
Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Faculty
Jeffrey Anderson, MD
Professor of Internal Medicine
University of Utah School of Medicine
Salt Lake City, UT

Karol Watson, MD, PhD
Associate Professor of Medicine
University of California - Los Angeles
Los Angeles, CA

Click Here to Register

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Supported by an educational grant from AstraZeneca Pharmaceuticals, LP.

This event is not part of the official Internal Medicine 2013 Educational Program.

Pre-registration is for planning purposes only.
For additional CME activities and online cme courses visit http://www.cmeplanet.com

Photo:
http://www.prlog.org/12078624/1